Drug Discovery Market: Global Market Size, Industry Trends, Leading Players, Market Share and Forecast 2019-2025

Drug Discovery Market by Type (Pharmacogenomics, High Throughput Screening, Genomics, Bioinformatics, Biochips, Nanotechnology, Others), by End User (Pharmaceutical Companies, Biopharmaceutical Companies, Biotech Companies, Research Institutes) – Global Trends, Market Size, Share, Growth, Research and Forecast 2019-2025

Orion Market Research (OMR), recently published a market research report on the drug discovery market. According to the OMR analysis, the drug discovery market is growing at a significant rate during 2019-2025. The drug discovery market has witnessed a significant growth due to increasing expenditure on healthcare. The drug discovery market is segmented on the basis of type, end users and geography. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis and analyst insights.

Full report of Drug Discovery Market is available at https://www.omrglobal.com/industry-reports/global-drug-discovery-market/

“The rising prevalence of health disorders such as genetic disorders, nervous system disorders, cardiovascular diseases, diabetes, and cancer are creating demand for drug discovery market. Cancer have major impact on global economies boosting the growth of drug discovery and development. According to National Cancer Institute, in 2016, a total of 1,685,210 new cancer cases and 595,690 deaths from cancer occur in the US. In addition, diabetes mellitus is chronic disease associated with severe life-long conditions including nerve damage, kidney diseases, CVDs, and eye diseases, that require intensive monitoring and control. The partial or completely decrease in the production of insulin and secretion by pancreatic beta cells is the reason for the diabetes to be caused. With this increasing prevalence, the market players are focused on the development of new drugs to improve the quality of life of the people. The market players hold a robust pipeline for new products. For example: some of the drugs that are in development by the company Evotec includes: EVT770 for type 1 and type 2 diabetes; CureNephron for chronic kidney disease and CureBeta for type 1 and type 2 diabetes.”

The global drug discovery market is geographically divided among four major regions – North America, APAC, Europe, and Rest of the world. North America is the leading market. The market is expected to grow at a stable CAGR. North American market is driven by due to the technological advancement in biotechnology and genomics and increasing investment in the healthcare infrastructure. Asia Pacific market is expected to have the highest CAGR amongst all regions for the forecast period of 2018-2023. The rising demand for novel drug discovery technologies in the APAC region due to rising population is backing the growth of the market in APAC region.

Market Segmentation
• Drug Discovery Market by Type
• Drug Discovery Market by End User

Region Covered
• North America (US and Canada)
• Europe (UK, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the World (Middle East & Africa and Latin America)

Company Profile
• Abbott Laboratories Inc.
• Albany Molecular Research
• ArQule, Inc.
• Bayer AG
• Bio-Rad Laboratories
• Boehringer Ingelheim

For related reports please visit https://www.omrglobal.com/reports-category/pharmaceuticals/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

This release was published on openPR.